Skip to main content
Premium Trial:

Request an Annual Quote

Wendy Britten

Congenica has named Wendy Britton chief financial officer, effective Sept. 1. Britten joins the British clinical genomics interpretation software vendor from AstraZeneca, where she led group finance business performance. In addition to the normal CFO responsibilities, Britten will have a say in Congenica's business development and future fundraising, the company said. In announcing Britten's hiring, Congenica disclosed that it raised $13.5 million in a Series B that concluded in April 2017, higher than the $10 million reported two months earlier.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.